trending Market Intelligence /marketintelligence/en/news-insights/trending/qVo5gDO14WI5L7K7VdckVg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Reata Pharmaceuticals withdraws $86.3M stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Reata Pharmaceuticals withdraws $86.3M stock offering

Reata Pharmaceuticals Inc. is withdrawing a registration statement for the sale of up to $86.3 million worth of class A common shares.

The shelf registration was filed earlier this month and is being withdrawn due to "unfavorable market conditions."